Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | BCHE | P06276 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PPM1B | O75688 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9067686 | 1.00 | CHRNB2 (0.41) | CHRNB2CHRNA5CHRNA7CHRNA4NPC1 | |
| SCHEMBL9067679 | 1.00 | CHRNB2 (0.41) | CHRNB2CHRNA5CHRNA7CHRNA4NPC1 | |
| SCHEMBL7639529 | 1.00 | CHRNB2 (0.41) | CHRNB2CHRNA5CHRNA7CHRNA4NPC1 | |
| SCHEMBL7639537 | 1.00 | CHRNB2 (0.41) | CHRNB2CHRNA5CHRNA7CHRNA4NPC1 | |
| SCHEMBL8524350 | 0.91 | CHRNB2 (0.41) | CHRNB2CHRNA5CHRNA7CHRNA4NPC1 | |
| SCHEMBL1087799 | 0.91 | CHRNB2 (0.41) | CHRNB2CHRNA5CHRNA7CHRNA4NPC1 | |
| SCHEMBL8470094 | 0.91 | CHRNB2 (0.41) | CHRNB2CHRNA5CHRNA7CHRNA4NPC1 | |
| SCHEMBL8524354 | 0.91 | CHRNB2 (0.41) | CHRNB2CHRNA5CHRNA7CHRNA4NPC1 | |
| SCHEMBL1087798 | 0.91 | CHRNB2 (0.41) | CHRNB2CHRNA5CHRNA7CHRNA4NPC1 | |
| SCHEMBL8470100 | 0.91 | CHRNB2 (0.41) | CHRNB2CHRNA5CHRNA7CHRNA4NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1473294-B1 | Substituted 1,3-oxathiolanes with antiviral properties | SHIRE BIOCHEM INC (CA) | 2007-04-18 | — | — | EP | disclosed |
| EP-1473294-A2 | Substituted 1,3-oxathiolanes with antiviral properties | Shire Biochem Inc. (CA) | 2004-11-03 | — | — | EP | disclosed |
| EP-1153924-B1 | Substituted 1,3-oxathiolanes with antiviral properties | SHIRE BIOCHEM INC (CA) | 2004-09-01 | — | — | EP | disclosed |
| US-6369066-B1 | HIV INFECTIONS | BIOCHEM PHARMA, INC. (CA) | 2002-04-09 | — | — | US | disclosed |
| EP-0756595-B1 | SUBSTITUTED 1,3-OXATHIOLANES WITH ANTIVIRAL PROPERTIES | SHIRE BIOCHEM INC (CA) | 2002-03-06 | — | — | EP | disclosed |
| EP-1153924-A2 | Substituted 1,3-oxathiolanes with antiviral properties | BIOCHEM PHARMA INC (CA) | 2001-11-14 | — | — | EP | disclosed |
| US-6228860-B1 | ADMINISTERING TO TREAT HUMAN IMMUNODEFICIENCY OR HEPATITIS VIRUS INFECTIONS IN MAMMALS RESISTANT TO 3TC OR FTC | BIOCHEM PHARMA INC. (CA) | 2001-05-08 | — | — | US | disclosed |
| EP-0756595-A1 | SUBSTITUTED 1,3-OXATHIOLANES WITH ANTIVIRAL PROPERTIES | BIOCHEM PHARMA INC (CA) | 1997-02-05 | — | — | EP | disclosed |
| US-5587480-A | TREATING HIV AND HEPATITIS VIRUS INFECTIONS | BIOCHEM PHARMA, INC. (CA) | 1996-12-24 | — | — | US | disclosed |
| WO-1995029176-A1 | SUBSTITUTED 1,3-OXATHIOLANES WITH ANTIVIRAL PROPERTIES | BIOCHEM PHARMA INC. (CA) | 1995-11-02 | — | — | WO | disclosed |